Vanguard Asset Management
TMDX icon

Vanguard Asset Management’s Transmedics TMDX Stock Holding History

Vanguard Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
32,680
+2,917
+10% +$247K ﹤0.01% 1514
2026
Q1 		$2.96M Buy
+29,763
New +$3.88M ﹤0.01% 1251

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Asset Management's TMDX Position: Q2 2026 in Review

Vanguard Asset Management increased its Transmedics (TMDX) stake by 9.8% in Q2 2026, buying an estimated $247K and bringing the position to 32,680 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Vanguard Asset Management first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.96M in Q1 2026. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Vanguard Asset Management held 32,680 shares of Transmedics worth $2.17M as of Q2 2026.
  • Vanguard Asset Management bought 2,917 Transmedics shares in Q2 2026, an estimated $247K.
  • Transmedics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1514 holding.
  • Vanguard Asset Management first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Transmedics position peaked at $2.96M in Q1 2026.
  • 368 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.